ArticleBlood cancer journal2023

Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

Rodrigo Fonseca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.